Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Mar 22;12(4):278-87.
doi: 10.1038/nrc3236.

Antibody Therapy of Cancer

Affiliations
Review

Antibody Therapy of Cancer

Andrew M Scott et al. Nat Rev Cancer. .

Abstract

The use of monoclonal antibodies (mAbs) for cancer therapy has achieved considerable success in recent years. Antibody-drug conjugates are powerful new treatment options for lymphomas and solid tumours, and immunomodulatory antibodies have also recently achieved remarkable clinical success. The development of therapeutic antibodies requires a deep understanding of cancer serology, protein-engineering techniques, mechanisms of action and resistance, and the interplay between the immune system and cancer cells. This Review outlines the fundamental strategies that are required to develop antibody therapies for cancer patients through iterative approaches to target and antibody selection, extending from preclinical studies to human trials.

Trial registration: ClinicalTrials.gov NCT00829166 NCT01120184.

Similar articles

See all similar articles

Cited by 574 articles

See all "Cited by" articles

References

    1. Expert Opin Biol Ther. 2010 Jan;10(1):1-18 - PubMed
    1. Sci Signal. 2009 Jun 30;2(77):ra31 - PubMed
    1. J Clin Oncol. 2010 Oct 1;28(28):4390-9 - PubMed
    1. Clin Transl Oncol. 2010 Apr;12(4):253-60 - PubMed
    1. J Clin Oncol. 2010 Jul 1;28(19):3167-75 - PubMed

Publication types

MeSH terms

Associated data

LinkOut - more resources

Feedback